SCIENTIFIC PROGRAMME of the pre-congress courses

ROOM 1

12:00 - 12:05

Introduction

Chair: Dr Jana Žodžika

12:05 - 12:35

Colposcopic principles

Speaker: Dr Annu Heinonen

12:35 - 13:00

Swede score

SpeakerDr Björn Strander

13:00 - 13:10

Break

13:10 - 14:10

Interactive sessions

Speaker: Dr Annu Heinonen, Dr Jana Žodžika, Mr Charles Redman & Dr Björn Strander

14:10 - 14:30

Break

14:30 - 15:00

Management

Speaker: Mr Charles Redman

15:00 - 16:00

Interactive sessions

Speaker: Dr Annu Heinonen, Dr Jana Žodžika, Mr Charles Redman & Dr Björn Strander

16:00 - 16:10

Break

16:10 - 17:00

Special cases

Chair: Dr Jana Žodžika

ROOM 2

12:00 - 18:00

Training the trainers

Speakers: Dr Maggie Cruickshank, Dr Xavier Carcopino, Dr Ameli Trope & Dr Theresa Freeman-Wang

SCIENTIFIC PROGRAMME of the 9° EFC CONGRESS

ROOM 1

08:30 - 09:00

Opening Ceremony

9:00 - 10:30

MSS1: Keynote 1

Chairs: Dr Pekka Nieminen, Finland & Dr Björn Strander, Sweden

  • Prophylactic vaccinations and the elimination of HPV and cervical cancer: Dr Joakim Dillner, Sweden
  • Prophylactic vaccination and eradication of oncogenic HPVs.: Dr Matti Lehtinen, Finland
  • Keynote Lecture 1c: HPV vaccination after treatment of CIN: Dr Maria Kyrgiou, UK
  • Q&A session

10:30 - 11:00

Break

11:00 - 12:30

MSS 2: Genetics and epigenetics: from HPV to cancer

Chairs: Dr Olaf Reich, Austria & Dr Karolina Louvanto, Finland

  • Genetic predisposition in cervical cancer: Dr Sarah Bowden, UK
  • Temporal sequence of somatic driver gene mutations in cervical carcinogenesis: Dr Sigrid Regauer, Austria
  • Epigenetic modification of cellular and HPV genomes: Dr Magnus von Knebel-Doeberitz, Germany
  • HPV genetics and genotype variation: Dr Karolina Louvanto, Finland
  • Q&A session

12:30 - 13:30

Break

13:30 - 15:00

MSS3: HPV screening now

Chairs: Dr Ameli Trope, Norway & Dr Marc Arbyn, Belgium

  • Validated hpv tests for screening: Dr Kate Cuschieri, UK
  • Triage of HPV+ in Denmark: Dr Jesper Bonde, Denmark
  • Self sampling: Dr Marc Arbyn, Belgium
  • Experience of self-sampling in the NL: Dr Sandra Van Dijk, The Netherlands
  • Q&A session

15:00 - 15:30

Break

15:30 - 17:00

MCS 3: Challenges in screening, diagnostic and follow-up: persistent HPV & posmenopausal women

Chairs: Dr Xavier Carcopino, France & Dr Anne Hammer, Denmark

  • Evidence for latent papillomavirus infections and their regulation: Dr John Doorbar, UK
  • Risk of HSIL and cancer in postmenopausal women and after cessation of screening: Dr Miriam Elfström, Sweden
  • Best management options for women with type 3 TZ: Dr Anne Hammer, Denmark
  • Dealing with persistent HPV following treatment of CIN: Dr Amelia Pedro, Portugal
  • Q&A session

17:00 - 17:30

Break

17:30 - 19:00

Virtual get together

ROOM 2

08:30 - 09:00

Opening Ceremony

09:00 - 10:00

Break

10:00 - 11:30

MCS 1: Follow-up and conservative treatment of CIN or SIL

Chairs: Dr Christine Bergeron, France & Dr Karoliina Aro, Finland

  • Post-treatment follow-up of CIN, test of cure and prognostic factors: Dr Efraim Siegler, Israel
  • Regression rate of HSIL of the cervix in women under the age of 25 years: Dr Monika Hampl, Germany
  • Conservative management of LSIL and CIN2 lesions: Dr Karoliina Aro, Finland
  • Alternative treatments for low grade lesions: Dr Peter Hillemans, Germany
  • The long term risk of HPV-related disease after CIN3 treatment: Dr Diede Loopik, The Netherlands
  • Q&A session

11:30 - 12:30

Break

12:30 - 14:00

MCS 2: Management of CIN

Chairs: Dr Evangelos Paraskevaidis, Greece & Mr Simon Leeson, UK

  • Cancer rate and recurrence after local treatment, comparisons between different methods: Dr Antonis Athanasiou, UK
  • Repeat local treatments, when, to whom and associated morbidity: Dr Pierre Martin-Hirsch, UK
  • Increased risk of cervical cancer post treatment and possible explanations: Dr Björn Strander, Sweden
  • Personalised management of women with cervical pathology incorporating lifestyle algorithms: Dr Evangelos Paraskevaidis, Greece
  • Q&A session

14:00 - 14:30

Break

14:30 - 15:00

Free Communications 1

15:00 - 15:30

Break

15:30 - 17:00

Colposcopy in practice – Cases 1

Chairs: Dr Robert Koiss, Hungary & Dr Marja Simojoki, Finland

  • Use of Iodine in colposcopy + introduction to SWEDE-score: Dr Björn Strander
  • Interactive cases: Several presentations

17:00 - 17:30

Break

17:30 - 19:00

Virtual get together

ROOM 3

08:30 - 09:00

Opening Ceremony

09:00 - 10:00

Colposcopy in the era of HPV vaccination – vulva and anus

Chairs: Dr Jacob Bornstein, Israel & Dr Maggie Cruickshank, UK

  • Diagnosis and treatment of AIN: Dr Tamzin Cuming, UK
  • Diagnosis and treatment of VIN: Dr J Bornstein, Israel
  • Q&A session

10:00 - 10:30

Break

10:30 - 12:00

Diagnostic Challenges of various vulvar symptoms

Chairs: Dr Päivi Tommola, Finland & Dr Eija Hiltunen-Back, Finland

  • Genital ulcers, differential diagnostics: Dr Eija Hiltunen-Back, Finland
  • What we know of and diagnostic challenges in vulvodynia: Dr Päivi Tommola, Finland
  • Acetic acid and vulva: clinical relevance: Dr Pia Halonen, Finland
  • Q&A session

12:00 - 13:00

Break

13:00 - 14:30

Vaginal Microbiome

Chairs: Dr Gilbert Donders, Belgium & Dr Jana Žodžika, Latvia

  • Cervical disease and vaginal microbiome: the systems biology: Dr Maria Kyrgiou, UK
  • HPV and fertility: Dr Gilbert Donders, Belgium
  • Different vaginal microflora types and CIN: Dr Olga Plisko, Latvia
  • Q&A session

14:30 - 15:00

Break

15:00 - 15:30

Free Communications 2

16:00 - 16:30

Break

16:30 - 17:30

Vaginal HSIL

Chairs: Dr Andrea Ciavattini, Italy & Dr Maija Jakobsson, Finland

  • HPV vaccination and vaginal HSIL lesions: Dr Jorma Paavonen, Finland
  • Imiquimod treatment for vaginal HSIL: Dr Karoliina Aro, Finland
  • Evidence-based treatment of vaginal HSIL: Dr Francesco Sopracordevole, Italy
  • Q&A session

17:30 - 18:30

Break

17:30 - 19:00

Virtual get together

ROOM 1

08:30 - 09:00

Break

9:00 - 10:30

MCS 4: Colposcopy and CIN during pregnancy

Chairs: Dr Efraim Siegler, Israel & Dr Mihaela Grigore, Romania

  • HPV and complications in pregnancy: Dr Anita Mitra, UK
  • Vertical transmission of HPV during pregnancy – what do we know?: Dr Mihaela Grigore, Romania
  • The difficulty of cervical cancer prevention by pap and colposcopy during pregnancy: Dr Cecilia Kärrberg, Sweden
  • The outcome of CIN 2-3 in pregnancy?  The best way of delivery: Dr Zvi Vaknin, Israel
  • Should CIN 2-3 be treated in pregnancy?: Dr Efraim Siegler, Israel
  • Q&A session

10:30 - 11:00

Break

11:00 - 12:30

MCS 6: Special cases in pathology, colposcopy, and treatment

Chairs: Dr Olaf Reich, Austria & Dr Laura Kotaniemi-Talonen, Finland

  • Immune microenvironment in SIL of the cervix: Dr Ruud Bekkers, The Netherlands
  • HPV-independent cervical cancer and precancer: Dr Miriam Elfström, Sweden
  • New concepts in excisional treatment of HSIL and AIS: Dr Olaf Reich, Austria
  • Challenges on the way of elImination of cervical cancer in Eastern Europa: Dr Natalia Volodko, Ukraine
  • Q&A session

12:30 - 13:30

Break

13:30 - 15:00

MSS 4: Prophylactic HPV-vaccines

Chairs: Dr Ruud Bekkers, The Netherlands & Dr Ilkka Kalliala, Finland

  • HPV type replacement after prophylactic vaccination: Dr Penelope Gray, Finland
  • HPV vaccines, CIN and preterm birth: Dr Ilkka Kalliala, Finland
  • Self sampling: Dr Marc Arbyn, Belgium
  • Experience of self-sampling in the NL: Dr Sandra Van Dijk, The Netherlands
  • HPV vaccination for high-risk adult women, including after CIN treatment: Dr Heleen van Beekhuizen, The Netherlands
  • Screening after HPV vaccination: Dr Peter Sasieni, UK
  • Q&A session

15:00 - 15:30

Break

15:30 - 16:30

Free Communications 5 (OP)

16:30 - 18:00

Break

19:00

Prizes

ROOM 2

08:30 - 09:30

Colposcopy in practice – Cases 2

Chairs: Dr Tamar Alibegashvili, Georgia & Dr Annu Heinonen, Finland

  • Interactive cases: Several presentations

09:30 - 10:00

Break

10:00 - 11:30

MCS 5: Keynote 2: future of screening and colposcopy

Chairs: Dr Maggie Cruickshank, UK & Dr Xavier Carcopino, France

  • Keynote Lecture 2a: The future of cervical cancer screening: Dr Mari Nygård, Norway
  • Keynote Lecture 2b: Triage and prognostic markers in cervical cancer screening: Dr Cara Martin, Ireland
  • Keynote Lecture 2c: QA of colposcopy for HPV-based screening programmes and HPV-vaccinated populations: Mr Simon Leeson, UK
  • Q&A session

11:30 - 12:30

Break

12:30 - 14:00

MCS 7: Guidelines and QI for colposcopy in Europe

Chairs: Mr Simon Leeson, UK & Mr Charles Redman, UK

  • European guidelines, where we are, the importance of consensus and linkage to QIs: Dr Maggie Cruickshank, UK
  • Influence of international guidelines: Dr Jean-Luc Mergui, France
  • Quality Indicators: relevant and reproducible?: Mr Simon Leeson, UK
  • Implementing international guidelines locally. The value of incorporation of international into national guidelines: Dr Maciej Mazurec, Poland
  • Q&A session

14:00 - 14:30

Break

14:30 - 15:30

Free Communications 4 (OP)

15:30 - 16:00

Break

16:00 - 17:30

MSS 5: The male factor in HPV transmission and vaccination programmes

Chairs: Dr Kristina Elfgren, Sweden & Dr Wiebren Tjalma, Belgium

17:30 - 18:00

Break

19:00

Prizes

ROOM 3

08:30 - 10:00

Free Communications 3

10:00 - 10:30

Break

10:30 - 12:00

Cervical Cancer Screening Audit and Medico-legal issues

Chairs: Mr Charles Redman, UK & Dr Volkmar Küppers, Germany

  • The potential of national cancer screening audit: Dr Peter Sasieni, UK
  • Swedish cancer screening audits: Dr Miriam Elfström, Sweden
  • English cancer screening audits: Dr Phillippa Pearman, UK
  • Disclosure of cervical cancer audit findings: Dr Theresa Freeman-Wang, UK
  • Q&A session

12:00 - 13:00

Break

13:00 - 14:30

Cervical cancer prevention in underscreened countries

Chairs: Dr Robert Jach, Poland, & Dr Jana Žodžika, Latvia

  • Prevention of cervical cancer in Serbia – opportunities and limitations: Dr Vesna Kesic, Serbia
  • How can we improve adherence to the screening?: Dr Michaela Grigore, Romania
  • Challenges of cervical cancer screening programme in Lithuania: Dr Kristina Jariene, Lithuania
  • HPV test as a primary screening tool in all resource settings (The Balkan Perspective): Dr Goran Dimitrov, Northern Macedonia
  • Is organized population-based model the universal strategy for all underscreened populations? – hybrid screening strategy as a chance for Poland: Dr Martyna Trzeszcz, Poland
  • Q&A session

14:30 - 15:00

Break

15:00 - 16:30

EFC General Assembly

16:30 - 18:00

Break

19:00

Prizes

ROOM 1

9:00 - 10:30

MCS 8: Improving selection of new technologies in colposcopy

Chairs: Mr Charles Redman, UK & Dr Tamar Alibegashvili, Georgia

  • Presentation of the Ulli Petry Prize: Dr Pekka Nieminen, Finland
  • Risk-based management focused on risk stratification – a multi parameter approach: Dr Martyna Trzeszcz, Poland
  • Improving diagnosis with Zedscan: Dr John Tidy, UK
  • Improving diagnosis with Dysis: Dr Jacqueline Louwers, The Netherlands
  • The potential role of AI in the Polish context: Dr Robert Jach, Poland
  • Q&A session

10:30 - 11:00

Break

11:00 - 12:30

MCS 9: Media coverage and social media

Chairs: Dr Ameli Trope, Norway & Dr Grainne Flannelly, Ireland

  • Setting the scene – The role of media and social media in establishing trust in cervical cancer prevention programmes: Dr Grainne Flannelly, Ireland
  • What women know about HPV and lessons learned about how this might affect uptake of a HPV based cervical screening programme: Dr Mairead O’Connor, Ireland
  • The use of social media campaigns to drive uptake of cervical screening in the UK: Dr Samantha Dickson, UK
  • Risk and benefits of LLETZ – what women really think and what lessons can we learn about influencing behaviour and establishing trust: Dr Ameli Trope, Norway
  • Using social media campaigns to tackle disinformation about HPV vaccination – a strategy that worked: Dr Muiriosa Ryan, Ireland

12:30 - 13:30

Closing remarks & Awards

ROOM 2

09:00 - 10:30

MSS 6: Impact of Covid-19 on cervical screening, prevention and prognosis

Chairs: Mr Simon Leeson, UK & Dr Xavier Carcopino, France

  • Impact of Covid-19 outbreak on cervical cancer screening throughout Europe: Dr Xavier Carcopino, France
  • BSCCP colposcopy training and the exit exam and what was done during Covid: Dr Deirdre Lyons, UK
  • Early lessons from the coronavirus pandemic for the cervical screening programme in Wales: Mr Simon Leeson, UK
  • Experience from the Netherlands with Covid and self-sampling: Dr Anne-Marie van Haaften-de-Jong, The Netherlands
  • Q&A session

10:30 - 11:00

Break

11:00 - 12:30

Round Table on The future roles for the EFC

Chairs: Dr Jens Quaas, Germany; Dr Rino Barbero, Italy; Mr Charles Redman, UK; Dr Pekka Nieminen, Finland & Dr Margaret Cruickshank, UK

What are the future priorities for the EFC and how should the EFC achieve these: Dr Robert Jach, Germany; Dr Volkmar Küppers, Germany; Dr Amelia Pedro, Portugal & Dr Ilkka Kalliala, Finland

12:30 - 13:30

Closing remarks & Awards